Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MERCAPTOPURINE ORAL SUSPENSION safely and effectively. See full prescribing information for MERCAPTOPURINE ORAL SUSPENSION. MERCAPTOPURINE oral suspension Initial U.S. Approval: 1953
Medication labelWhy this: Advisory · dailymed-prescription
Mercaptopurine is indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.
- generic_name
- mercaptopurine
- product_names
- MERCAPTOPURINE
- ndc
- 0054-4582, 0054-4582-49
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en